pyrazines has been researched along with Co-infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, T; Kondo, Y; Miyazaki, S; Yamashita, R | 1 |
| Antonini, M; Capobianchi, MR; Di Caro, A; Ippolito, G; Kobinger, GP; Lanini, S; Lauria, FN; Magrini, N; Nicastri, E; Petrosillo, N; Puro, V; Shindo, N | 1 |
2 other study(ies) available for pyrazines and Co-infection
| Article | Year |
|---|---|
Coinfection with SARS-CoV-2 and influenza A virus.
Topics: Amides; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; Coinfection; Coronavirus Infections; COVID-19; Diagnosis, Differential; Glucocorticoids; Humans; Influenza A virus; Influenza, Human; Lung; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pregnenediones; Pyrazines; Radiography; Real-Time Polymerase Chain Reaction; SARS-CoV-2 | 2020 |
Ebola virus disease complicated with viral interstitial pneumonia: a case report.
Topics: Amides; Antibodies, Monoclonal; Antiviral Agents; Coinfection; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Lung Diseases, Interstitial; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Pyrazines; Respiration, Artificial; Respiratory Insufficiency; RNA, Viral; Viral Load | 2015 |